Cite
HARVARD Citation
Minacapelli, C. et al. (2019). MiR-206 as a Biomarker for Response to Mesalamine Treatment in Ulcerative Colitis. Inflammatory bowel diseases. 25 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Minacapelli, C. et al. (2019). MiR-206 as a Biomarker for Response to Mesalamine Treatment in Ulcerative Colitis. Inflammatory bowel diseases. 25 (1), p. . [Online].